Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Bio-Rad, Beckman Coulter extend 10- year partnership:

This article was originally published in Clinica

Executive Summary

Bio-Rad Laboratories (Hercules, California) has agreed to develop new immunoassays for Beckman Coulter's UniCel and Access immunoassay systems, including Hepatitis B envelope antigen and antibody, under an extension to an agreement that began in 1997. Beckman Coulter vice-president of the immunoassay business centre Richard Creager said the deal will add significant value for blood virus and infectious disease testing laboratories and gain market share in the $1.6bn worldwide blood virus and infectious disease area. Fullerton California-based Beckman Coulter last month lost out to Inverness Medial Innovations in a bidding race for Biosite (see Clinica No 1256, p 2)





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts